CVS Health (CVS) concluded the recent trading session at $79.43, signifying a +0.14% move from its prior day's close.
With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem.

Three-Stock Lunch: Visa, McCormick, and CVS

03:18pm, Tuesday, 26'th Mar 2024
Malcolm Ethridge, CIC Wealth Executive Vice President, joins 'Power Lunch' to discuss his investing take on three stocks: Visa, McCormick, and CVS.

Final Trades: Target, Costco and CVS

01:53pm, Tuesday, 26'th Mar 2024
The Investment Committee give you their top stocks to watch for the second half.
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
In the most recent trading session, CVS Health (CVS) closed at $78.06, indicating a +0.63% shift from the previous trading day.
As the broader stock rally broadens to some of the more “boring” corners of the market, it's the higher-yielding dividend plays that could stand to move higher from current levels. Undoubtedly, a

CVS downgraded as vet probe drums up concerns

08:01am, Friday, 15'th Mar 2024
CVS Group (AIM:CVSG), the veterinary service provider, has been downgraded to "sector perform" by analysts at RBC following the CMA's review of the industry. The group's price target has also been red
CVS Group (AIM:CVSG) PLC has said proposals are already available to address competition concerns in Britain's veterinary sector, after news of a probe stripped a quarter of its value on Tuesday. Pets
CVS Health is a lot more than just a chain of retail pharmacies. Aetna, one of America's largest health insurance companies, is a CVS Health subsidiary.
CVS Health reported solid full-year results for fiscal 2023, but already had to lower its guidance for fiscal 2024. During the 2023 investor day, CVS also lowered its long-term guidance but is still e

CVS Health: Better Times Likely Ahead

12:55am, Tuesday, 12'th Mar 2024
CVS Health and the healthcare services sector are facing numerous challenges in 2024, including cyber attacks, regulatory scrutiny, declining COVID-related sales, and lower CMS rates. The company is a
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health's strong position and comprehensive healthcare operations make it a solid long-term pick. Fiverr should benefit from the growing gig economy, a trend that has accelerated in recent years.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE